Prescription study shows modest increase in spending


Per CVS Caremark's (CVS) Insights report prescription drug trend rose 3.8% last year versus flat growth in 2012. Growth drivers were price inflation and increased utilization (more prescriptions per member).

Specialty medications that treat more complex diseases grew by 15.6%.

The company generates the report, which includes an outline of cost containment strategies, to assist payers with their management of prescription drug spending.

Drug trend is the measure of growth in prescription spending per member per month.

The generic dispensing rate was 81.4%.

(RAD) (WAG)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs